All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
19Feb20 07:00 RNS Novacyt -25.82% Health £67.8m Exercise of Warrants and Issue of Equity
18Feb20 16:30 RNS Novacyt -25.82% Health £67.8m Exercise of Warrants and Issue of Equity
18Feb20 09:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
18Feb20 09:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
18Feb20 07:00 RNS Novacyt -25.82% Health £67.8m Exercise of Warrants and Issue of Equity
17Feb20 16:40 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
17Feb20 16:35 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
17Feb20 14:06 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
17Feb20 14:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
17Feb20 12:30 RNS Novacyt -25.82% Health £67.8m Launch of CE-IVD Marked novel coronavirus test
17Feb20 11:06 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
17Feb20 11:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
17Feb20 09:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
17Feb20 09:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
14Feb20 15:20 RNS Novacyt -25.82% Health £67.8m Update on CE Mark Approved coronavirus test
14Feb20 11:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
14Feb20 11:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
11Feb20 16:40 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
11Feb20 16:35 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
11Feb20 14:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
11Feb20 14:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
11Feb20 11:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
10Feb20 14:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
10Feb20 14:01 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
10Feb20 11:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
10Feb20 11:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
07Feb20 16:40 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
07Feb20 16:35 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
07Feb20 09:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
07Feb20 07:00 RNS Novacyt -25.82% Health £67.8m Update on novel coronavirus test
05Feb20 11:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
05Feb20 11:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
03Feb20 16:45 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
03Feb20 11:05 RNS Novacyt -25.82% Health £67.8m Second Price Monitoring Extn
03Feb20 11:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
03Feb20 09:00 RNS Novacyt -25.82% Health £67.8m Price Monitoring Extension
31Jan20 18:15 RNS Novacyt -25.82% Health £67.8m Exercise of Warrants and Issue of Equity
31Jan20 07:00 RNS Novacyt -25.82% Health £67.8m Launch of novel coronavirus test
28Jan20 07:00 RNS Novacyt -25.82% Health £67.8m Full Year Trading and Operational Update
17Jan20 07:00 RNS Novacyt -25.82% Health £67.8m Primerdesign partners with VGS Group in France
02Jan20 10:30 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement Update and Total Voting Rights
27Dec19 07:00 RNS Novacyt -25.82% Health £67.8m Completion of NOVAprep® business sale
02Dec19 14:16 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
06Nov19 07:00 RNS Novacyt -25.82% Health £67.8m New term loan and termination of bond facility
01Nov19 13:30 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
07Oct19 07:00 RNS Novacyt -25.82% Health £67.8m Molecular respiratory panel ready for US market
03Oct19 16:15 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
01Oct19 14:30 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
27Sep19 15:23 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
26Sep19 07:00 RNS Novacyt -25.82% Health £67.8m Half Year Results
25Sep19 15:46 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
23Sep19 13:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
18Sep19 14:45 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
12Sep19 15:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
11Sep19 17:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
02Sep19 13:00 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
28Aug19 17:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
27Aug19 07:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
12Aug19 16:45 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
07Aug19 11:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
02Aug19 15:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
02Aug19 14:00 RNS Novacyt -25.82% Health £67.8m Change of Adviser
01Aug19 10:45 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
30Jul19 07:00 RNS Novacyt -25.82% Health £67.8m Half-Year Trading Update
19Jul19 08:12 RNS Novacyt -25.82% Health £67.8m Replacement Result of AGM
19Jul19 07:03 RNS Novacyt -25.82% Health £67.8m Result of AGM
18Jul19 15:30 RNS Novacyt -25.82% Health £67.8m Sale of Clinical Lab
18Jul19 11:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
16Jul19 16:30 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
09Jul19 13:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
01Jul19 11:00 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
28Jun19 16:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
26Jun19 10:30 RNS Novacyt -25.82% Health £67.8m Annual General Meeting Update
24Jun19 16:15 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
21Jun19 16:18 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
20Jun19 13:55 RNS Novacyt -25.82% Health £67.8m Annual General Meeting Update
20Jun19 13:55 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
19Jun19 07:00 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
14Jun19 14:45 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
03Jun19 14:00 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
24May19 07:00 RNS Novacyt -25.82% Health £67.8m Publication of Annual Report and Notice of AGM
17May19 16:35 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
15May19 17:30 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
13May19 07:00 RNS Novacyt -25.82% Health £67.8m Launch of Next-Generation qPCR Instrument
03May19 18:23 RNS Novacyt -25.82% Health £67.8m Conversion of Loan Notes
03May19 07:00 RNS Novacyt -25.82% Health £67.8m Change of Adviser
01May19 17:30 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement
30Apr19 07:00 RNS Novacyt -25.82% Health £67.8m Full Year 2018 Results
25Apr19 07:00 RNS Novacyt -25.82% Health £67.8m Update on Notice of Full Year Results
23Apr19 07:00 RNS Novacyt -25.82% Health £67.8m Convertible Bond Facility
08Apr19 07:00 RNS Novacyt -25.82% Health £67.8m Expanded Development Partnership with Immunexpress
01Apr19 14:30 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
04Mar19 07:00 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
26Feb19 07:00 RNS Novacyt -25.82% Health £67.8m Funding Update
01Feb19 14:00 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
22Jan19 07:00 RNS Novacyt -25.82% Health £67.8m Revenues Full Year 2018
02Jan19 12:30 RNS Novacyt -25.82% Health £67.8m Liquidity Agreement and Total Voting Rights
24Dec18 07:00 RNS Novacyt -25.82% Health £67.8m Trading Update
21Dec18 07:00 RNS-R Novacyt -25.82% Health £67.8m Novacyt launches two new molecular diagnostic kits
11Dec18 07:00 RNS Novacyt -25.82% Health £67.8m Update on Strategic Review
Date / Time Source Company % Chg
19Feb20 07:00 RNS Novacyt -25.82%
Exercise of Warrants and Issue of Equity
18Feb20 16:30 RNS Novacyt -25.82%
Exercise of Warrants and Issue of Equity
18Feb20 09:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
18Feb20 09:00 RNS Novacyt -25.82%
Price Monitoring Extension
18Feb20 07:00 RNS Novacyt -25.82%
Exercise of Warrants and Issue of Equity
17Feb20 16:40 RNS Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 16:35 RNS Novacyt -25.82%
Price Monitoring Extension
17Feb20 14:06 RNS Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 14:00 RNS Novacyt -25.82%
Price Monitoring Extension
17Feb20 12:30 RNS Novacyt -25.82%
Launch of CE-IVD Marked novel coronavirus test
17Feb20 11:06 RNS Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 11:00 RNS Novacyt -25.82%
Price Monitoring Extension
17Feb20 09:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 09:00 RNS Novacyt -25.82%
Price Monitoring Extension
14Feb20 15:20 RNS Novacyt -25.82%
Update on CE Mark Approved coronavirus test
14Feb20 11:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
14Feb20 11:00 RNS Novacyt -25.82%
Price Monitoring Extension
11Feb20 16:40 RNS Novacyt -25.82%
Second Price Monitoring Extn
11Feb20 16:35 RNS Novacyt -25.82%
Price Monitoring Extension
11Feb20 14:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
11Feb20 14:00 RNS Novacyt -25.82%
Price Monitoring Extension
11Feb20 11:00 RNS Novacyt -25.82%
Price Monitoring Extension
10Feb20 14:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
10Feb20 14:01 RNS Novacyt -25.82%
Price Monitoring Extension
10Feb20 11:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
10Feb20 11:00 RNS Novacyt -25.82%
Price Monitoring Extension
07Feb20 16:40 RNS Novacyt -25.82%
Second Price Monitoring Extn
07Feb20 16:35 RNS Novacyt -25.82%
Price Monitoring Extension
07Feb20 09:00 RNS Novacyt -25.82%
Price Monitoring Extension
07Feb20 07:00 RNS Novacyt -25.82%
Update on novel coronavirus test
05Feb20 11:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
05Feb20 11:00 RNS Novacyt -25.82%
Price Monitoring Extension
03Feb20 16:45 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
03Feb20 11:05 RNS Novacyt -25.82%
Second Price Monitoring Extn
03Feb20 11:00 RNS Novacyt -25.82%
Price Monitoring Extension
03Feb20 09:00 RNS Novacyt -25.82%
Price Monitoring Extension
31Jan20 18:15 RNS Novacyt -25.82%
Exercise of Warrants and Issue of Equity
31Jan20 07:00 RNS Novacyt -25.82%
Launch of novel coronavirus test
28Jan20 07:00 RNS Novacyt -25.82%
Full Year Trading and Operational Update
17Jan20 07:00 RNS Novacyt -25.82%
Primerdesign partners with VGS Group in France
02Jan20 10:30 RNS Novacyt -25.82%
Liquidity Agreement Update and Total Voting Rights
27Dec19 07:00 RNS Novacyt -25.82%
Completion of NOVAprep® business sale
02Dec19 14:16 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
06Nov19 07:00 RNS Novacyt -25.82%
New term loan and termination of bond facility
01Nov19 13:30 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
07Oct19 07:00 RNS Novacyt -25.82%
Molecular respiratory panel ready for US market
03Oct19 16:15 RNS Novacyt -25.82%
Conversion of Loan Notes
01Oct19 14:30 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
27Sep19 15:23 RNS Novacyt -25.82%
Conversion of Loan Notes
26Sep19 07:00 RNS Novacyt -25.82%
Half Year Results
25Sep19 15:46 RNS Novacyt -25.82%
Conversion of Loan Notes
23Sep19 13:00 RNS Novacyt -25.82%
Conversion of Loan Notes
18Sep19 14:45 RNS Novacyt -25.82%
Conversion of Loan Notes
12Sep19 15:00 RNS Novacyt -25.82%
Conversion of Loan Notes
11Sep19 17:00 RNS Novacyt -25.82%
Conversion of Loan Notes
02Sep19 13:00 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
28Aug19 17:00 RNS Novacyt -25.82%
Conversion of Loan Notes
27Aug19 07:00 RNS Novacyt -25.82%
Conversion of Loan Notes
12Aug19 16:45 RNS Novacyt -25.82%
Conversion of Loan Notes
07Aug19 11:00 RNS Novacyt -25.82%
Conversion of Loan Notes
02Aug19 15:00 RNS Novacyt -25.82%
Conversion of Loan Notes
02Aug19 14:00 RNS Novacyt -25.82%
Change of Adviser
01Aug19 10:45 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
30Jul19 07:00 RNS Novacyt -25.82%
Half-Year Trading Update
19Jul19 08:12 RNS Novacyt -25.82%
Replacement Result of AGM
19Jul19 07:03 RNS Novacyt -25.82%
Result of AGM
18Jul19 15:30 RNS Novacyt -25.82%
Sale of Clinical Lab
18Jul19 11:00 RNS Novacyt -25.82%
Conversion of Loan Notes
16Jul19 16:30 RNS Novacyt -25.82%
Conversion of Loan Notes
09Jul19 13:00 RNS Novacyt -25.82%
Conversion of Loan Notes
01Jul19 11:00 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
28Jun19 16:00 RNS Novacyt -25.82%
Conversion of Loan Notes
26Jun19 10:30 RNS Novacyt -25.82%
Annual General Meeting Update
24Jun19 16:15 RNS Novacyt -25.82%
Conversion of Loan Notes
21Jun19 16:18 RNS Novacyt -25.82%
Conversion of Loan Notes
20Jun19 13:55 RNS Novacyt -25.82%
Annual General Meeting Update
20Jun19 13:55 RNS Novacyt -25.82%
Conversion of Loan Notes
19Jun19 07:00 RNS Novacyt -25.82%
Conversion of Loan Notes
14Jun19 14:45 RNS Novacyt -25.82%
Conversion of Loan Notes
03Jun19 14:00 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
24May19 07:00 RNS Novacyt -25.82%
Publication of Annual Report and Notice of AGM
17May19 16:35 RNS Novacyt -25.82%
Conversion of Loan Notes
15May19 17:30 RNS Novacyt -25.82%
Conversion of Loan Notes
13May19 07:00 RNS Novacyt -25.82%
Launch of Next-Generation qPCR Instrument
03May19 18:23 RNS Novacyt -25.82%
Conversion of Loan Notes
03May19 07:00 RNS Novacyt -25.82%
Change of Adviser
01May19 17:30 RNS Novacyt -25.82%
Liquidity Agreement
30Apr19 07:00 RNS Novacyt -25.82%
Full Year 2018 Results
25Apr19 07:00 RNS Novacyt -25.82%
Update on Notice of Full Year Results
23Apr19 07:00 RNS Novacyt -25.82%
Convertible Bond Facility
08Apr19 07:00 RNS Novacyt -25.82%
Expanded Development Partnership with Immunexpress
01Apr19 14:30 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
04Mar19 07:00 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
26Feb19 07:00 RNS Novacyt -25.82%
Funding Update
01Feb19 14:00 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
22Jan19 07:00 RNS Novacyt -25.82%
Revenues Full Year 2018
02Jan19 12:30 RNS Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
24Dec18 07:00 RNS Novacyt -25.82%
Trading Update
21Dec18 07:00 RNS-R Novacyt -25.82%
Novacyt launches two new molecular diagnostic kits
11Dec18 07:00 RNS Novacyt -25.82%
Update on Strategic Review
Date / Time Company % Chg
19Feb20 07:00 Novacyt -25.82%
Exercise of Warrants and Issue of Equity
18Feb20 16:30 Novacyt -25.82%
Exercise of Warrants and Issue of Equity
18Feb20 09:05 Novacyt -25.82%
Second Price Monitoring Extn
18Feb20 09:00 Novacyt -25.82%
Price Monitoring Extension
18Feb20 07:00 Novacyt -25.82%
Exercise of Warrants and Issue of Equity
17Feb20 16:40 Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 16:35 Novacyt -25.82%
Price Monitoring Extension
17Feb20 14:06 Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 14:00 Novacyt -25.82%
Price Monitoring Extension
17Feb20 12:30 Novacyt -25.82%
Launch of CE-IVD Marked novel coronavirus test
17Feb20 11:06 Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 11:00 Novacyt -25.82%
Price Monitoring Extension
17Feb20 09:05 Novacyt -25.82%
Second Price Monitoring Extn
17Feb20 09:00 Novacyt -25.82%
Price Monitoring Extension
14Feb20 15:20 Novacyt -25.82%
Update on CE Mark Approved coronavirus test
14Feb20 11:05 Novacyt -25.82%
Second Price Monitoring Extn
14Feb20 11:00 Novacyt -25.82%
Price Monitoring Extension
11Feb20 16:40 Novacyt -25.82%
Second Price Monitoring Extn
11Feb20 16:35 Novacyt -25.82%
Price Monitoring Extension
11Feb20 14:05 Novacyt -25.82%
Second Price Monitoring Extn
11Feb20 14:00 Novacyt -25.82%
Price Monitoring Extension
11Feb20 11:00 Novacyt -25.82%
Price Monitoring Extension
10Feb20 14:05 Novacyt -25.82%
Second Price Monitoring Extn
10Feb20 14:01 Novacyt -25.82%
Price Monitoring Extension
10Feb20 11:05 Novacyt -25.82%
Second Price Monitoring Extn
10Feb20 11:00 Novacyt -25.82%
Price Monitoring Extension
07Feb20 16:40 Novacyt -25.82%
Second Price Monitoring Extn
07Feb20 16:35 Novacyt -25.82%
Price Monitoring Extension
07Feb20 09:00 Novacyt -25.82%
Price Monitoring Extension
07Feb20 07:00 Novacyt -25.82%
Update on novel coronavirus test
05Feb20 11:05 Novacyt -25.82%
Second Price Monitoring Extn
05Feb20 11:00 Novacyt -25.82%
Price Monitoring Extension
03Feb20 16:45 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
03Feb20 11:05 Novacyt -25.82%
Second Price Monitoring Extn
03Feb20 11:00 Novacyt -25.82%
Price Monitoring Extension
03Feb20 09:00 Novacyt -25.82%
Price Monitoring Extension
31Jan20 18:15 Novacyt -25.82%
Exercise of Warrants and Issue of Equity
31Jan20 07:00 Novacyt -25.82%
Launch of novel coronavirus test
28Jan20 07:00 Novacyt -25.82%
Full Year Trading and Operational Update
17Jan20 07:00 Novacyt -25.82%
Primerdesign partners with VGS Group in France
02Jan20 10:30 Novacyt -25.82%
Liquidity Agreement Update and Total Voting Rights
27Dec19 07:00 Novacyt -25.82%
Completion of NOVAprep® business sale
02Dec19 14:16 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
06Nov19 07:00 Novacyt -25.82%
New term loan and termination of bond facility
01Nov19 13:30 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
07Oct19 07:00 Novacyt -25.82%
Molecular respiratory panel ready for US market
03Oct19 16:15 Novacyt -25.82%
Conversion of Loan Notes
01Oct19 14:30 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
27Sep19 15:23 Novacyt -25.82%
Conversion of Loan Notes
26Sep19 07:00 Novacyt -25.82%
Half Year Results
25Sep19 15:46 Novacyt -25.82%
Conversion of Loan Notes
23Sep19 13:00 Novacyt -25.82%
Conversion of Loan Notes
18Sep19 14:45 Novacyt -25.82%
Conversion of Loan Notes
12Sep19 15:00 Novacyt -25.82%
Conversion of Loan Notes
11Sep19 17:00 Novacyt -25.82%
Conversion of Loan Notes
02Sep19 13:00 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
28Aug19 17:00 Novacyt -25.82%
Conversion of Loan Notes
27Aug19 07:00 Novacyt -25.82%
Conversion of Loan Notes
12Aug19 16:45 Novacyt -25.82%
Conversion of Loan Notes
07Aug19 11:00 Novacyt -25.82%
Conversion of Loan Notes
02Aug19 15:00 Novacyt -25.82%
Conversion of Loan Notes
02Aug19 14:00 Novacyt -25.82%
Change of Adviser
01Aug19 10:45 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
30Jul19 07:00 Novacyt -25.82%
Half-Year Trading Update
19Jul19 08:12 Novacyt -25.82%
Replacement Result of AGM
19Jul19 07:03 Novacyt -25.82%
Result of AGM
18Jul19 15:30 Novacyt -25.82%
Sale of Clinical Lab
18Jul19 11:00 Novacyt -25.82%
Conversion of Loan Notes
16Jul19 16:30 Novacyt -25.82%
Conversion of Loan Notes
09Jul19 13:00 Novacyt -25.82%
Conversion of Loan Notes
01Jul19 11:00 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
28Jun19 16:00 Novacyt -25.82%
Conversion of Loan Notes
26Jun19 10:30 Novacyt -25.82%
Annual General Meeting Update
24Jun19 16:15 Novacyt -25.82%
Conversion of Loan Notes
21Jun19 16:18 Novacyt -25.82%
Conversion of Loan Notes
20Jun19 13:55 Novacyt -25.82%
Annual General Meeting Update
20Jun19 13:55 Novacyt -25.82%
Conversion of Loan Notes
19Jun19 07:00 Novacyt -25.82%
Conversion of Loan Notes
14Jun19 14:45 Novacyt -25.82%
Conversion of Loan Notes
03Jun19 14:00 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
24May19 07:00 Novacyt -25.82%
Publication of Annual Report and Notice of AGM
17May19 16:35 Novacyt -25.82%
Conversion of Loan Notes
15May19 17:30 Novacyt -25.82%
Conversion of Loan Notes
13May19 07:00 Novacyt -25.82%
Launch of Next-Generation qPCR Instrument
03May19 18:23 Novacyt -25.82%
Conversion of Loan Notes
03May19 07:00 Novacyt -25.82%
Change of Adviser
01May19 17:30 Novacyt -25.82%
Liquidity Agreement
30Apr19 07:00 Novacyt -25.82%
Full Year 2018 Results
25Apr19 07:00 Novacyt -25.82%
Update on Notice of Full Year Results
23Apr19 07:00 Novacyt -25.82%
Convertible Bond Facility
08Apr19 07:00 Novacyt -25.82%
Expanded Development Partnership with Immunexpress
01Apr19 14:30 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
04Mar19 07:00 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
26Feb19 07:00 Novacyt -25.82%
Funding Update
01Feb19 14:00 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
22Jan19 07:00 Novacyt -25.82%
Revenues Full Year 2018
02Jan19 12:30 Novacyt -25.82%
Liquidity Agreement and Total Voting Rights
24Dec18 07:00 Novacyt -25.82%
Trading Update
21Dec18 07:00 Novacyt -25.82%
Novacyt launches two new molecular diagnostic kits
11Dec18 07:00 Novacyt -25.82%
Update on Strategic Review